ArticleCNS drugs2021
Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients.
Senta Frol et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it